ImmunoGen (IMGN) Misses Q2 View By 3c
More News related to IMGN
- ImmunoGen, Inc. Announces Webcast of Panel Session at the RBC Capital Markets 2008 Healthcare Conference
- ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
- ImmunoGen, Inc. Appoints James J. O'Leary, MD, as Vice President and Chief Medical Officer
- ImmunoGen, Inc. Earns $4 Million Milestone Payment with sanofi-aventis' Initiation of a Phase II Trial with AVE1642
- ImmunoGen (IMGN) Tops Q3 View By A Penny
More News related to Earnings
- Research and Markets: Coffeeheaven Case Study Report: Growing Brand Share in the Nascent Central and Eastern European Coffee Market
- Ericsson and Telstra world's first to deliver Mobile Broadband at 21Mbps in commercial network
- SEK's financing capacity further strengthened
- SDRL - Seadrill secures new long-term tender rig contract in West-Africa
- WebTech Wireless Schedules First Quarter Financial Results Conference Call
ImmunoGen, Inc. (Nasdaq: IMGN) reports a Q2 loss of $0.27, 3 cents below the analyst estimate of ($0.24). Revenues for the quarter were $4.5 million, versus the consensus of $9.96 million.
Related Categories
EarningsStocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
